Current Studies

Click on a study for more information
Alzheimer's Disease (click here)

We are currently enrolling in studies for Alzheimer’s Disease.

Please contact Estela at 619-432-0867.

Simufilam 50 mg Or 100 mg For Mild-To-Moderate Alzheimer’s Disease (REFOCUS_ALZ).https://clinicaltrials.gov/ct2/show/NCT05026177

For more information, you can visit the patient website by clicking here

Assessment of safety and efficacy measured by amyloid reduction of remternetug in early symptomatic Alzheimer’s Disease. https://clinicaltrials.gov/ct2/show/NCT05463731?term=J1G-MC-LAKC&draw=2&rank=1

Please contact Estela at 619-432-0867.

Myasthenia Gravis (click here)

We are currently enrolling in studies for Myasthenia Gravis.

Please contact Lupe at 619-432-0954.

Descartes-08 CAR-T Cells In Generalized Myasthenia Gravis (MG).https://clinicaltrials.gov/ct2/show/NCT04146051

A Phase 3, Multi-center, Randomized, Quadruple‑blind, Placebo-controlled Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants with Generalized Myasthenia Gravis (gMG).https://clinicaltrials.gov/ct2/show/NCT05403541?id=IMVT+1401-3101&draw=2&rank=1

FLEX Research Study for Adults with Generalized Myasthenia Gravis (gMG)

The FLEX study is a randomized, blinded, and placebo-controlled study assessing the efficacy and safety of an investigational drug for adults diagnosed with gMG. The injectable investigational drug is being evaluated over a 12-week induction period and a 12-week maintenance period. Based on completion of these periods and a participant’s response to the investigational drug, participation in a 52-week extension study of the investigational drug may be available to study participants. To learn more, please contact <<contact info>> www.gMG-research.com 

Multiple Sclerosis (click here)

We are currently enrolling in studies for Multiple Sclerosis.

Please contact Lupe at 619-432-0954.

A Study To Evaluate The Efficacy And Safety of Fenebrutinib Compared With Teriflunomide In Relapsing Multiple Sclerosis (RMS) (Fenhance) .https://clinicaltrials.gov/ct2/show/NCT04586010

For more information, you can visit the patient website by clicking here.

Migraine (Click Here)

We are currently enrolling in studies for Migraine.

Please contact Erin at 760-227-9912

A Phase 3 Multicenter 24-Week Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Atogepant When Added to OnabotulinumtoxinA (BOTOX) for the Preventive Treatment of Chronic Migraine. https://clinicaltrials.gov/ct2/show/NCT05216263?intr=atogepant&draw=2&rank=4

Current Areas of Research

Alzheimer's Disease/Dementia
Multiple Sclerosis (MS)
Myasthenia Gravis (MG)
Migraine

Menu